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The ability of injured axons to regenerate declines
with age, yet the mechanisms that regulate axon
regeneration in response to age are not known.
Here we show that axon regeneration in aging
C. elegans motor neurons is inhibited by the
conserved insulin/IGF1 receptor DAF-2. DAF-2’s
function in regeneration is mediated by intrinsic
neuronal activity of the forkhead transcription factor
DAF-16/FOXO. DAF-16 regulates regeneration inde-
pendently of lifespan, indicating that neuronal aging
is an intrinsic, neuron-specific, and genetically regu-
lated process. In addition, we found that DAF-18/
PTEN inhibits regeneration independently of age
and FOXO signaling via the TOR pathway. Finally,
DLK-1, a conserved regulator of regeneration, is
downregulated by insulin/IGF1 signaling, bound by
DAF-16 in neurons, and required for both DAF-16-
and DAF-18-mediated regeneration. Together, our
data establish that insulin signaling specifically in-
hibits regeneration in aging adult neurons and that
this mechanism is independent of PTEN and TOR.
INTRODUCTION
Axon regeneration has the potential to repair damaged neurons
in response to injury. However, across species, the regenerative
potential of injured neurons decreases with age. For example, in
the mammalian peripheral nervous system, where regeneration
does occur in adults, regenerative potential is lower in old
animals (Pestronk et al., 1980; Tanaka et al., 1992; Verdu´ et al.,
1995, 2000). In C. elegans, axon regeneration also declines dur-
ing adulthood (Gabel et al., 2008; Hammarlund et al., 2009; Nix
et al., 2011; Wu et al., 2007; Zou et al., 2013). In animals with a
mature nervous system, the various effects of age on axon
regeneration could be a secondary consequence of aging’s
deleterious effects on the organism as a whole or a result of
interactions between neurons and an aging cellular environment.
Alternatively, the effects of age could be part of a specific pro-
gram executed in neurons. Understanding the mechanisms
that regulate the decline of regeneration with age could help
inform therapies for age-related changes in neuronal function,disease, and recovery. However, the mechanisms that mediate
the decline of regeneration in adults are not well understood.
To characterize a neuron’s response to age and injury, we
investigated age-related decline in axon regeneration in
C. elegans. C. elegans is a leading genetic model of aging
(Antebi, 2007; Kenyon, 2010). Moreover, C. elegans has a well-
characterized, invariant nervous system and has recently
emerged as a model for neuronal aging (White et al., 1986; Pan
et al., 2011; Tank et al., 2011; Toth et al., 2012). Finally,
C. elegans is a powerful system for studying axon regeneration
(Chen and Chisholm, 2011; El Bejjani and Hammarlund, 2012).
Individual postdevelopmental C. elegans axons are readily
amenable to pulsed laser axotomy, and their regeneration is
easily visualized in vivo (Byrne et al., 2011; Gabel et al., 2008;
Hammarlund et al., 2009; Rao et al., 2008; Wu et al., 2007; Yanik
et al., 2004). Thus, the worm holds the potential to identify
mechanisms that regulate how age alters the response of
neurons to injury.
Here we analyze how age affects regeneration in the GABA
motor neurons of adult C. elegans. We show that as adult
animals age, these neurons exhibit decreased retraction,
decreased growth response, and decreased extension in
response to nerve injury. We show that this decline in regenera-
tion is regulated by the insulin/IGF1 receptor daf-2 and the fork-
head transcription factor daf-16/FOXO. daf-16 functions cell
intrinsically in neurons to regulate regeneration independently
of daf-16’s function in lifespan determination. The conserved
phosphatase daf-18/protein phosphatase and tensin homolog
(PTEN) (deleted on chromosome 10) also regulates regeneration
yet does so in an age- and insulin-independent manner, via
target of rapamycin (TOR) signaling. Moreover, regeneration in
both daf-2 and daf-18 mutants requires the critical dlk-1/DLK
plasticity pathway. Our findings demonstrate that age-related
decline in adult axon regeneration is an intrinsic, neuron-specific,
and genetically regulated process and define separable func-
tions for the INSR/IGF1R-FOXO and the PTEN-TOR pathways
in regulating axon regeneration an aged animals.
RESULTS
Insulin/IGF1 Signaling Inhibits Axon Regeneration and
Does so Specifically in Aged Animals
We investigated the relationship between axon regeneration and
age using single-neuron pulsed-laser surgery in adult C. elegans
GABAmotor neurons (Figure 1A). To address the effects of adultNeuron 81, 561–573, February 5, 2014 ª2014 Elsevier Inc. 561
Figure 1. Regeneration Declines in Aged
Animals
(A) GABA commissures are severed with a pulsed
laser and scored for regeneration after 24 hr in
young adult (1-day adult, L4 + 1 day at 25C) and
aged adult (5-day adult, L4 + 5 days at 25C)
animals.
(B and C) GABA commissures 24 hr after being
severed in (B) 1-day adult wild-type and (C) 5-day
adult wild-type animals. All animals contain
Punc-47::GFP, which drives GFP expression
specifically in the GABA motor neurons.
(D) Comparison of axon regeneration frequency in
young and aged wild-type animals. Regeneration
in 5-day adult animals is significantly reduced
relative to 1-day adult animals (p < 0.01, Fisher’s
exact test). Error bars represent 95% confidence
intervals.
(E) Regenerating axons were binned into four
categories (depicted in A) based on how far they
had extended. Regeneration categories were as
follows: ML, indicating axons that did not extend
past the midline; ML, indicating axons that
extended to the midline; ML+, indicating axons
that extended three-quarters of the distance
between the ventral and dorsal cords; and Full,
indicating axons that fully regeneration to the
dorsal cord.
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compared regeneration of severed axons at two adult time
points: 1-day adults, aged 1 day past the final larval stage (young
adults) and 5-day adults, aged 5 days past the final larval stage
(aged adults). These adult time points occur well after the GABA
neurons complete development by forming functional synaptic
connections onto their final postsynaptic targets—a process
that is finished by the second of four larval stages that precede
adulthood in the C. elegans life cycle (Wood, 1988). We found
that in young adult wild-type animals, 65% of axons regenerated
in response to injury (Figures 1B and 1D), consistent with previ-
ous reports (Hammarlund et al., 2009). By contrast, in aged adult
wild-type animals, few axons (28%) initiated a regeneration
response to injury (Figures 1C and 1D). Therefore, axon regener-
ation declines in adulthood, in large part due to failure in aged
animals of growth cone initiation in response to nerve injury.
Axon regeneration is a complex, multistep process in which
the injured neuron must respond to injury by initiating a growth
cone and then sustain axon extension toward the appropriate
target. To characterize the effect of age on regeneration, we
binned cut axons into four categories based on how far they562 Neuron 81, 561–573, February 5, 2014 ª2014 Elsevier Inc.had regenerated toward their target, the
dorsal nerve cord (Figures 1A–1D). We
found that in aged animals, even axons
that did regenerate in response to injury
were defective at extension toward the
target. Of the severed axons that did
regenerate in aged adult wild-type ani-
mals, only 12% made substantial prog-
ress toward the dorsal nerve cord
(Figure 1E; ML and ML versus ML+
and Full). By contrast, in young adult animals, 31% of regenerat-
ing axons made substantial progress toward the dorsal nerve
cord after 24 hr (Figure 1E). Thus, of the few axons that do regen-
erate in aged adult animals, 88% fail to extend toward their tar-
gets in the dorsal nerve cord. Therefore, both axon initiation and
extension after nerve injury are inhibited in aged adult animals
relative to young adult animals. Together, these deficiencies
result in an overall failure of axon regeneration in 5-day wild-
type adults, in stark contrast to the robust axon regeneration
observed in wild-type adults that are 4 days younger.
We hypothesized that the age-related decline in GABA axon
regeneration might be suppressed by manipulations that delay
aging and increase lifespan. We tested axon regeneration in
several well-characterized models that increase lifespan,
including animals that have decreased insulin signaling (daf-2
mutants) (Kenyon et al., 1993; Kimura et al., 1997), animals
that overexpress sirtuin and have an additional lifespan-
increasing mutation (sir-2.1OE mutants) (Tissenbaum and
Guarente, 2001; Viswanathan and Guarente, 2011), and animals
that are calorically restricted as a result of eating difficulty (eat-2
mutants) (Avery, 1993; Lakowski and Hekimi, 1998). Of these
Figure 2. daf-2 Inhibits the Number of
Regenerating Axons and Limits Their Exten-
sion during Early Senescence
(A) GABA commissures 24 hr after being severed in
5-day adult wild-type and 5-day adult daf-2(e1370)
animals.
(B) Quantification of regeneration in 5-day adult
wild-type and daf-2(e1370) animals 24 hr after
axotomy. Regeneration in 5-day adult daf-2()
animals is significantly increased relative to 5-day
adult wild-type animals (p < 0.01; Fisher’s exact
test).
(C) Regenerating axons were binned into cate-
gories according to how far they extended toward
the dorsal nerve cord (categories described in
Figure 1). More severed axons in aged adult daf-
2() animals extend significantly (ML+ and Full)
compared to severed axons in aged adult wild-
type animals (p < 0.01; Fisher’s exact test).
(D) Axon regeneration frequencies in wild-type and
daf-2(e1370) animals of increasing age.
(E) Lengths of commissural fragments 24 hr after
axotomy in 5-day adults. Width represents
commissure length prior to axotomy. For preci-
sion, axons were severed on the ventral side of the
seam cells, which are located at the midline. All
animals express the Punc-47::GFP reporter. Error
bars represent 95% confidence intervals in (B) and
(D) and standard error in (E).
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tion (p > 0.3; Fisher’s exact test). However, modification of insulin
signaling by mutating the insulin/insulin-like growth factor 1 re-
ceptor (INSR/IGF1R) DAF-2 enhanced regeneration in aged
adults. We found that in contrast to wild-type animals, 5-day
adult daf-2()mutants exhibited no decline in axon regeneration
(Figures 2A and 2B). daf-2 regulates regeneration specifically in
aged animals, as the frequency of regeneration in young adult
daf-2() mutants was indistinguishable from that in young adult
wild-type animals (Figure 2D). Therefore, daf-2 specifically regu-
lates an age-related decline in axon regeneration.
We characterized the specific effects of daf-2 on age-related
regeneration using the same categorical analysis as described
above (Figures 2A and 2C). In contrast to aged wild-type ani-
mals, only 30% of axons in aged daf-2() mutants failed to
respond to injury. Therefore, daf-2 inhibits growth cone initiation
in aged axons. Furthermore, in contrast to the 12% of wild-type
axons that made substantial progress toward the dorsal nerve
cord in wild-type animals, approximately 48% of regenerating
axons made considerable progress toward, or reached, the dor-
sal nerve cord in daf-2() mutants (Figure 2C; ML+ and Full).
These results indicate that daf-2 inhibits both growth cone initi-
ation and axon growth in aged animals.
To confirm that the failure of axons in aged wild-type animals
to regenerate past themidline is due to defects in growth and not
inaccurate axon guidance, we measured the length of severed
axons. We found that 24 hr after being cut, axons were signifi-
cantly longer in daf-2() mutants than in wild-type animals
(Figure 2E). Interestingly, retraction after injury was also affected
by daf-2. After axotomy in young animals, the injured ends of theaxon retract away from the cut site (Hammarlund et al., 2009).
We found that this retraction was reduced or absent in aged
wild-type animals (Figure 2E). The average length of the distal
(dorsal) commissural fragments of injured axons in aged wild-
type animals extended just ventral of the midline, consistent
with a lack of retraction away from the cut site (Figures 2A and
2E). By contrast, we observed axon retraction in the distal
(dorsal) commissural fragments of injured axons in aged daf-
2() animals (Figures 2A and 2E). Further, the average length
of the distal (dorsal) commissural fragments of injured axons in
these animals did not reach the midline, consistent with retrac-
tion away from the cut site (Figures 2A and 2C). Together, these
results suggest that axon retraction is compromised in aged
animals—possibly due to a lack of elasticity—and show that
this defect is rescued in daf-2() animals. Further, these results
show that the increased regeneration we observe in aged daf-
2() animals is not because the daf-2() axons retract less: in
fact, daf-2() axons retract more and also regenerate farther.
Therefore, daf-2 regulates growth rather than guidance of regen-
erating axons.
Although lack of daf-2 extended the ability of wild-type ani-
mals to regenerate, it did not do so indefinitely. The frequency
of axon regeneration in daf-2() mutants declined by 10 days
postdevelopment (Figure 2D). However, even in these old
animals, some degree of axon regeneration was still present in
daf-2() animals. By contrast, in wild-type animals 10 days post-
development, regeneration was never observed (Figure 2D). In
summary, our results demonstrate that the INS/IGF1 receptor
DAF-2 regulates both growth cone initiation and axon extension
in aged adult animals after injury.Neuron 81, 561–573, February 5, 2014 ª2014 Elsevier Inc. 563
Figure 3. daf-16 Mediates Age-Dependent
Regeneration Downstream of daf-2
(A and B) (A) Comparison of axon regeneration
frequencies in aged adult insulin pathway mutants
binned into categories (B) described in Figure 1.
(C) 5-day adult and 10-day adult time points are
indicated on the lifespans of wild-type (blue),
daf-2(e1370) (purple), daf-16(mu86) (green), and
daf-2(e1370); daf-16(mu86) (orange) animals.
(D) A simplified representation of the insulin/IGF1
signaling pathway. daf-16 regulates regeneration
downstream of daf-2 in aged adults either (i)
directly or (ii) indirectly. Error bars represent 95%
confidence intervals.
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DAF-16/FOXO
daf-2/INSR/IGF1R regulates lifespan by activating mechanisms
that sequester the forkhead transcription factor daf-16/FOXO
in the cytoplasm, thus preventing daf-16/FOXO from translocat-
ing to the nucleus and regulating transcription of effector genes
(Henderson and Johnson, 2001; Kenyon et al., 1993; Lee et al.,
2001; Lin et al., 2001). Mutations that disrupt daf-2/INSR/
IGF1R result in a 2-fold increase in lifespan that is dependent
on daf-16/FOXO (Kenyon et al., 1993). To test whether inhibition
of regeneration by daf-2 also functions by inhibiting daf-16, we
assessed regeneration in mutants that lacked both daf-2 and
daf-16. We found that eliminating daf-16 in daf-2() mutants
abolished the high regeneration normally observed in aged
daf-2() mutants (Figures 3A and 3B). By contrast, axons in
aged animals lacking only daf-16 regenerated similarly to wild-
type axons (Figures 3A and 3B), consistent with the finding
that daf-16/FOXO activity is mostly inhibited in wild-type animals
(Lin et al., 2001). Therefore, daf-2 inhibits regeneration in aged
animals by preventing daf-16 function.
DAF-16/FOXO Regulates Regeneration Independently
of Its Role in Lifespan Determination
The effects we observed of daf-2 and daf-16 on axon regenera-
tion correlate with their effects on lifespan (Figures 3A and 3C).
daf-2() mutants live longer, and their axons regenerate well
when aged; animals lacking both daf-2 and daf-16 do not live564 Neuron 81, 561–573, February 5, 2014 ª2014 Elsevier Inc.longer, and their axons do not regenerate
well when aged. One possible model to
explain this finding is that increased
axon regeneration in 5-day adult daf-
2() mutants is a secondary conse-
quence of delayed aging (Figure 3D,
hatched arrow ii). However, not all manip-
ulations that affect lifespan also affect
axon regeneration (see sir-2.1 and eat-2,
above), as would be expected if the
decline in axon regeneration were sec-
ondary to senectitude. Further, the steep
decline in regeneration that we observe
in 5-day-aged wild-type adults occurs
well before significant age-related mor-
tality (Figure 3C). Even at 10 days, whenboth wild-type animals and daf-2 mutants have lost all or most
regenerative ability (Figure 2D), mortality is limited (Figure 3C).
Together, these data suggest that senectitude and loss of regen-
erative ability are separable phenomena but that both are regu-
lated by daf-2 and daf-16 (Figure 3D, hatched arrow i).
To test the idea that age-related loss of axon regeneration
and lifespan are separately regulated, we attempted to
decouple the two phenotypes using daf-16() mosaic animals
(Figure 4). Although daf-16/FOXO is required for lifespan exten-
sion in daf-2/INSR/IGF1Rmutants, restoring daf-16 to the intes-
tine of daf-2(); daf-16() double mutants (intestine::daf-16*) is
sufficient to increase their lifespan (Libina et al., 2003). We
reasoned that if daf-16 function in neurons—rather than daf-
16 function in lifespan extension—is required to increase regen-
eration in aged animals, the intestine::daf-16* animals should fail
to regenerate when aged, even though they have increased life-
spans. We found that intestine::daf-16* animals did exhibit
increased lifespan compared to controls, consistent with previ-
ous results (Libina et al., 2003) (Figures 4A and 4B, +Pges-1:daf-
16; Figure S1 available online). However, 5-day adult intestine::
daf-16* animals showed a low level of axon regeneration that
was similar to wild-type (Figures 4C and 4D). Thus, despite
increasing the lifespan of daf-2(); daf-16() double mutants,
intestinal DAF-16 expression did not affect age-related decline
of regeneration (Figures 4B and 4C, +Pges-1:daf-16). We
conclude that daf-16 and insulin/IGF1 signaling can regulate
lifespan independently of regeneration and that increased
Figure 4. daf-16 Mediates Age-Dependent Regeneration Indepen-
dently of Lifespan
(A–E) We assessed lifespan and regeneration in (A) aged daf-2(e1370); daf-
16(mu86) worms expressing daf-16 in the intestine (Pges-1::daf-16) and in the
nervous system (Prgef-1::daf-16).
(B) Lifespans of daf-2(e1370); daf-16(mu86) (charcoal), with intestinal (blue) or
neuronal (red) daf-16 expression.
(C) Regeneration of aged daf-2(e1370); daf-16(mu86) worms expressing daf-
16 in the nervous system (Prgef-1::daf-16) and in the intestine (Pges-1::daf-16).
(D) Regenerating axons were binned into categories described in Figure 1.
Error bars represent 95% confidence intervals. See also Figure S1.
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animals.
These results suggested that daf-16might function in neurons
to increase regeneration in aged animals. Indeed, the growth
potential of injured axons depends in part on intrinsic factors
(Neumann et al., 2002; Neumann and Woolf, 1999; Qiu et al.,
2002). Thus, daf-16/FOXO could regulate axon regeneration
by acting directly in neurons. If so, we reasoned thatneuron-specific daf-16 expression might rescue age-related
regeneration in a daf-2(); daf-16() background. We expressed
wild-type daf-16 under the control of the pan-neuronal promoter
Prgef-1 in daf-2(); daf-16()mutants (neuron:daf-16*). In these
animals, daf-16 is expressed only in neurons, where it is active
due to the lack of daf-2. Neuronal-specific expression of daf-
16 had no effect on lifespan (Figures 4A and 4B, Prgef-1::daf-
16). However, aged neuron:daf-16* animals had improved
axon regeneration compared to controls, even though they did
not live any longer (Figures 4B and 4C, Prgef-1::daf-16). These
results show that daf-16 function in neurons is sufficient to regu-
late axon regeneration.
Although neuron-specific expression of daf-16 improved axon
regeneration in aged daf-2(); daf-16() mutants, it was not as
robust as axon regeneration in aged daf-2()mutants (compare
Figures 3B and 4D). This partial rescue may simply be the result
of differences in neuronal expression of daf-16 between the
endogenous locus and the Prgef-1-driven transgene. Alterna-
tively, it may be an indication that while neuronal daf-16 is neces-
sary and sufficient to promote regeneration, robust regeneration
also requires daf-16 function outside the nervous system.
Indeed, daf-16 has recently been shown to promote develop-
mental neuronal migration (Christensen et al., 2011; Kennedy
et al., 2013). Together, our data demonstrate that age-related
decline of regeneration is not a secondary consequence of
lifespan-related aging and define a new function for daf-16 in
regulating axon regeneration cell-autonomously in the aging
nervous system.
DAF-18/PTEN Inhibits Regeneration Independently of
Age and DAF-16/FOXO
Like daf-16/FOXO, daf-18/PTEN (protein phosphatase and
tensin homolog deleted on chromosome 10) is required for life-
span extension in daf-2/INSR/IFG1R mutants (Dorman et al.,
1995; Larsen et al., 1995). However, unlike daf-16, which posi-
tively regulates regeneration in daf-2() mutants (Figure 3A),
PTEN inhibits axon regeneration in mice and flies (Christie
et al., 2010; Liu et al., 2010; Park et al., 2008; Song et al.,
2012b; Sun et al., 2011). To determine the role of PTEN in axon
regeneration in C. elegans, we assessed regeneration in young
and aged adult daf-18/PTEN mutants. We found that like loss
of daf-2, loss of daf-18/PTEN significantly increased regenera-
tion in aged adults (Figures 2B and 5B). However, unlike daf-2
(which had no effect on young animals), loss of daf-18/PTEN
also increased regeneration in young adults (Figures 2D and
5A). The increase in regeneration in aged daf-18/PTEN mutants
was not as large as that seen in aged daf-2 mutants (Figures
5B and 2B), and regenerating axons in aged daf-18/PTEN
mutants often had a less robust growth structure (Figures 5D
and 2C). Nonetheless, these data indicate that PTEN’s role as
an inhibitor of axon regeneration is conserved in C. elegans.
Although loss of daf-18/PTEN and daf-2/INSR/IGF1R both
result in increased regeneration in aged adults, the two muta-
tions have different effects on lifespan. Loss of daf-2/INSR/
IGF1R increases lifespan, and this increase depends on daf-
16/FOXO activation (Henderson and Johnson, 2001; Kenyon
et al., 1993; Lee et al., 2001; Lin et al., 2001). By contrast, loss
of daf-18/PTEN decreases lifespan and can suppress bothNeuron 81, 561–573, February 5, 2014 ª2014 Elsevier Inc. 565
Figure 5. DAF-18/PTEN Does Not Regulate Regeneration via DAF-16/FOXO in Aged Animals
(A and B) (A) Axon regeneration frequency of young and (B) aged animals. *p < 0.05; **p < 0.01; ***p < 0.001, relative to equivalently aged wild-type, using Fisher’s
exact test.
(C and D) (C) Regenerating axons of young adult and (D) aged adult animals were binned into categories described in Figure 1.
(E) Lifespan analysis of various daf-18 mutants.
(F) Quantification of axon regeneration in aged animals of the indicated genotypes.
(G) Axon regeneration frequency of aged wild-type, daf-18(mg198), and daf-18(mg198) animals with extrachromosomal Punc-47::daf-18cDNA, which is
expressed in GABA neurons. *p < 0.05, relative to daf-18(mg198), using Fisher’s exact test.
(H) Model of interactions between components of the age-related regeneration response. In contrast to the mechanisms of lifespan determination, daf-18/PTEN
regulates regeneration independently of daf-16/FOXO and daf-2/INSR/IGF1R. In all panels, daf-2(), daf-16(), and daf-18() represent daf-2(e1370),
daf-16(mu86), and daf-18(mg198), respectively. Error bars represent 95% confidence intervals.
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Figure 6. DAF-18/PTEN, but Not Insulin,
Regulates Regeneration via TOR Signaling
(A) Representative images of axon regeneration
wild-type and daf-18(mg198) animals aged on
DMSO or rapamycin plates.
(B) Axon regeneration frequencies of aged adult
animals placed on rapamycin or DMSO as indi-
cated. Error bars represent 95% confidence
intervals. (*p < 0.05, relative to daf-18(mg198)
DMSO, using Fisher’s exact test).
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(Dorman et al., 1995; Larsen et al., 1995; Masse et al., 2005;
Ogg and Ruvkun, 1998) (Figure 5E). Since daf-18/PTENmutants
have shorter lives than wild-type animals (Dorman et al., 1995;
Larsen et al., 1995) (Figure 5E) but retain the ability to regenerate
axons when aged (Figure 5B), the loss of PTEN is another way
(besides daf-16 mosaics—see Figure 4) to decouple lifespan
and axon regeneration in aged animals. Further, the finding
that daf-18 and daf-2 both increase regeneration despite having
opposite effects on lifespan suggests that they may regulate
axon regeneration by different mechanisms.
To determine whether enhanced regeneration in daf-18/PTEN
is due to the same mechanism as enhanced regeneration in daf-
2mutants, we determined its dependence on daf-16. In contrast
to daf-2mutants, which increase regeneration (and lifespan) in a
daf-16-dependent manner (Kenyon et al., 1993), we found that
axon regeneration in PTEN mutants was independent of daf-
16. In aged adults, axons in animals that lacked both daf-18
and daf-16 (daf-18(mg150); daf-16(mu86)) regenerated as
frequently as axons in daf-18(mg150) animals (Figure 5B). This
lack of interaction between daf-18/PTEN and daf-16/FOXO in
regulating axon regeneration was also observed in animals that
lacked daf-2/INSR/IFG1R: we observed no difference in axon
regeneration between aged daf-2(e1370); daf-18(mg198) and
aged daf-2(e1370); daf-18(mg198); daf-16(mu86) animals
(Figure 5F). In addition, we found that GABA-specific daf-18
expression (driven by the unc-47 [vesicular GABA transporter]
promoter) inhibits regeneration in aged daf-18() mutants
(Figure 5G). Therefore, daf-18 functions cell intrinsically to inhibit
axon regeneration, independently of insulin signaling and FOXO.
Another important output of PTEN activity is inhibition of the
TOR pathway (Song et al., 2012a). Mutation of PTEN results in
increased AKT activity, leading to increased phosphorylation
and reduced activity of the TSC complex (Maehama and Dixon,
1998; Song et al., 2012a; Stambolic et al., 1998; Sun et al., 1999).
In turn, reduced TSC activity results in increased signaling by
TOR (Manning and Cantley, 2003). We investigated whetherNeuron 81, 561–573increased TOR activity might account for
the effect of loss of PTEN on axon regen-
eration in agedC. elegansGABA neurons.
We inhibited TOR with rapamycin and
found that had no effect on control ani-
mals, suggesting that TOR signaling is
not a major component of axon regenera-
tion in aged wild-type animals. By
contrast, rapamycin treatment abolishedthe increased axon regeneration phenotype of daf-18/PTEN
mutants (Figure 6). These results suggest that daf-18/PTEN’s
function in regeneration is mediated by TOR in C. elegans.
TOR has previously been shown to mediate the effect of PTEN
on axon regeneration in mammals (Christie et al., 2010; Liu
et al., 2010; Park et al., 2008; Song et al., 2012b; Sun et al.,
2011). Thus, the PTEN-TOR axis represents a conserved mech-
anism that regulates axon regeneration across species.
Next, we tested whether activated TOR might also mediate
the effect of loss of DAF-2 on axon regeneration in aged
animals. We found that regeneration in aged daf-2(e1370) mu-
tants is not affected by rapamycin (Figure 6). Therefore daf-2/
INSR/IGF1R functions independently of TOR to regulate
regeneration, in contrast to daf-18/PTEN. These findings
strengthen our conclusion that, despite functioning in the
same pathway to regulate lifespan, DAF-18/PTEN and insulin
signaling function independently of one another to regulate
axon regeneration: DAF-18/PTEN signaling functions via regu-
lation of TOR and insulin signaling functions via regulation of
DAF-16 activity.
DLK-1 Is Required for DAF-2- and DAF-18-Mediated
Regeneration
The strong and cell-autonomous regulation of regeneration by
the transcription factor daf-16/FOXO suggests that trans-
criptional regulation of one or more neuronal genes accounts
for the DAF-16-dependent increase in axon regeneration we
observe in aged daf-2() mutants. One potential target of such
regulation is the genes of the dlk-1 MAP kinase pathway—
the best-characterized intrinsic regeneration pathway in
C. elegans. dlk-1/DLK-1 is a conserved dual-leucine zipper
kinaseMAPKKK that functions in axon regeneration by activating
mkk-4/MAPKK and pmk-3/MAPK (Hammarlund et al., 2009;
Nakata et al., 2005; Yan et al., 2009). Activated pmk-3/MAPK
promotes regeneration at least in part by posttranscriptional
stabilization of the mRNA for the B-Zip protein cebp-1/C/EBP1,
likely via mak-2/MAPKAP2 (Yan et al., 2009). dlk-1 is also, February 5, 2014 ª2014 Elsevier Inc. 567
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Figure 7. Insulin Signaling Regulates Expres-
sion of DLK-1/DLK
(A) Axon regeneration frequency of aged animals of the
indicated genotypes. Due to space restrictions, daf-
2(), daf-16(), and daf-18() represent daf-2(e1370),
daf-16(mu86), and daf-18(mg198) respectively. Error
bars represent 95% confidence intervals.
(B) Quantitative RT-PCR analysis of DLK-1 pathway
genes in aged daf-2(e1370) animals. All values were
normalized to ama-1 expression levels and to relative
mRNA expression in aged wild-type animals. Error bars
represent 95% confidence intervals.
(C and D) (C) daf-2(e1370); daf-16(mu86) animals
expressing GFP-tagged DAF-16A fused to either an
intestinal (spl-1) or a (D) neuronal (rgef-1) promoter.
GFP::DAF-16A expression was restricted to the intes-
tinal nuclei (arrow, inset) when fused to the intestinal
promoter and was restricted to neuronal nuclei
(arrowhead, inset) when fused to the neuronal pro-
moter. Background intestinal autofluorescence was
observed in both strains. Scale bars represent 10 mm.
(E) Tissue-specific DAF-16A binding profiles of strains
presented in (C) and (D). Profiles span the dlk-1 locus
(bordered by dashed lines) on chromosome 1 (LG I).
(F) Magnification of DAF-16A binding profiles at the
dlk-1 locus. In neurons, two regions in the dlk-1 pro-
moter/locus were significantly enriched for DAF-16A
bound sequences (pink asterisks). In the intestine, three
regions in the dlk-1 promoter/locus were bound by
DAF-16A (green asterisks). See also Figure S2.
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(Hammarlund et al., 2009; Nakata et al., 2005; Yan et al., 2009).
DLK-1pathway function is required cell autonomously to regulate
regeneration across species (Hammarlund et al., 2009; Itoh et al.,
2009; Shin et al., 2012; Watkins et al., 2013; Xiong et al., 2010).
Overexpression of dlk-1 in GABA neurons confers an increase
in regenerative potential to both young and aged animals (Ham-
marlund et al., 2009), without increasing lifespan (Figure S2).
Therefore, the dlk-1 MAP kinase pathway is a candidate target
for daf-16-mediated regulation of age-related regeneration.
To investigate whether dlk-1 functions with daf-16 to regulate
regeneration, we first performed genetic epistasis experiments
between dlk-1 and daf-16 (Figure 7A). We found that dlk-1 is
absolutely required for regeneration in aged daf-2(), and aged
daf-18()mutants (Figure 7A) (Hammarlund et al., 2009). In addi-
tion, dlk-1 overexpression was sufficient to rescue regeneration
in daf-16 mutants. Since dlk-1 is also absolutely necessary and
sufficient for regeneration in aged wild-type animals, these
results indicate that dlk-1 functions downstream or in parallel
to daf-16 and daf-18.568 Neuron 81, 561–573, February 5, 2014 ª2014 Elsevier Inc.To test whether the dlk-1 MAP kinase
pathway is regulated in an age-dependent
manner by daf-16, we compared the expres-
sion levels of dlk-1 pathway genes in aged
wild-type and daf-2() mutants (in which
daf-16 function is elevated) using quantitative
RT-PCR. We found that in aged daf-2()
mutants, expression of three dlk-1 pathway
genes were specifically increased comparedto wild-type: dlk-1, mak-2, and cebp-1 (Figures 7B and S2).
The increase we observe in cebp-1 expression may be a sec-
ondary consequence of dlk-1 upregulation, since dlk-1 activity
increases cebp-1 mRNA levels by mak-2-mediated posttran-
scriptional stabilization (Yan et al., 2009).
Next, we asked whether daf-16 directly regulates one or more
dlk-1 pathway components. To do so, we examined data from
two independent methods—chromatin immunoprecipitation
sequencing (ChIP-seq) and DNA adenine methyltransferase
identification (DamID)—that identified physical interactions
between DAF-16 and the genome. We found that, uniquely
among dlk-1 pathway genes, DAF-16 physically interacts with
dlk-1 by both ChIP-seq and DamID (Celniker et al., 2009;
Schuster et al., 2010). Further, the physical interaction between
DAF-16 and the dlk-1 promoter region is partially organized
around canonical DAF-16 binding sites. Together, these findings
indicate that DAF-16 binds to dlk-1 and may regulate its activity.
With respect to regeneration, DAF-16 functions specifically in
the nervous system (Figure 4). We used tissue-specific ChIP-seq
data to investigate whether DAF-16 binds directly to dlk-1 in
Neuron
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(Frøkjær-Jensen et al., 2012) were used to make transgenes
that expressed GFP-tagged DAF-16A under either a neuronal
(rgef-1) or an intestinal (spl-1) promoter. Integrated transgenes
were placed in a background of daf-2 mutation (to activate
nuclear translocation of the GFP-tagged DAF-16) and daf-16
mutation (to avoid competition from untagged DAF-16). An
anti-GFP antibody was used to perform ChIP-seq from each of
the two resulting strains. Two replicates each of neuronal and
intestinal DAF-16A-bound DNA were sequenced and analyzed.
Overall, the analysis identified 1,526 DAF-16 binding sites in
neurons and 6,525 binding sites in intestine (unpublished data;
Figures 7E and 7F). Consistent with previous results, the canon-
ical DAF-16 binding element (TGTTTAC; Murphy et al., 2003)
was significantly overrepresented in the 500 most enriched
sequences in both tissues (e values are 1.3 3 1014 for neurons
and 1.6 3 1043 for intestine) (Bailey et al., 2009).
Analysis of the ChIP-seq data demonstrated that DAF-16
binds the dlk-1 promoter directly in neurons (Figure 7F). DAF-
16 also binds dlk-1 in the intestine. However, the binding profiles
at the dlk-1 locus differ in neurons and in the intestine (Figure 7F).
In neurons, DAF-16 bound two peaks. In the intestine, DAF-16
bound three peaks, one of which was also bound by DAF-16 in
neurons. Together with the evidence that daf-16 functions cell
autonomously in neurons to regulate regeneration (Figure 4)
and that dlk-1 expression is regulated in an age- and daf-16-
dependent manner (Figures 7B and S2), these results suggest
that one effect of DAF-16 activity in aged animals is to increase
expression of dlk-1 in neurons.
Together, our data demonstrate that one notable difference
between aged wild-type and daf-2() animals is expression of
dlk-1 pathway genes and suggest that increased dlk-1 pathway
activity in neurons—perhaps due to binding and direct regulation
of dlk-1 by neuronal DAF-16—contributes to high regeneration in
aged daf-2 animals.
DISCUSSION
INSR/IGFR1 and FOXO Function Independently of PTEN
and TOR to Regulate Axon Regeneration in Aged
Neurons
Axon regeneration in adult C. elegans declines dramatically with
age. In this study, we show that this decline is not a secondary
consequence of organismal aging but is an intrinsic property
of aging neurons themselves. We identify two independent
neuronal mechanisms that regulate axon regeneration in the
GABA neurons of aged animals: activity of the transcription
factor DAF-16/FOXO, potentially via the dlk-1/DLK regeneration
pathway, and activity of the lipid phosphatase DAF-18/PTEN, via
regulation of TOR.
DAF-16 Protects an Aging Nervous System
Our results show that the insulin signaling pathway acts in aged
animals to inhibit regeneration via regulation of daf-16 activity in
the nervous system. In the absence of insulin signaling,
increased daf-16 activity allows the neuron to regenerate in
response to injury. Recently, insulin signaling and daf-16 were
also shown to regulate the maintenance of neuronal morphologyin aging animals. Themechanosensory neurons (as well as some
other neuronal types) accumulate aberrant branches and other
morphological defects in an age-dependent manner, and accu-
mulation of defects is delayed in daf-2()mutant animals, which
have increased DAF-16 activity (Pan et al., 2011; Tank et al.,
2011; Toth et al., 2012). Together, these data suggest that insulin
signaling and DAF-16/FOXO regulate multiple protective pro-
cesses in aging neurons, including the ability to regenerate in
response to injury and the ability to maintain axon morphology.
The functions of DAF-16 in aging neurons are likely complex.
Activated daf-16 enhances regenerative growth after laser injury
(Figure 3A) but suppresses aberrant growth in neurons that have
not received an external injury (Pan et al., 2011; Tank et al., 2011;
Toth et al., 2012). Further, regeneration in aged animals is depen-
dent on the dlk-1MAP kinase pathway (Figure 7), while aberrant
growth is independent of the dlk-1 pathway (Tank et al., 2011).
Finally, although in aged animals both axon regeneration and
maintenance of morphology are both regulated by insulin
signaling and daf-16, the effects of aging occur at different rates.
We found that insulin signaling acts at an early stage of adult
life—between 1 and 5 days—to inhibit daf-16 and reduce regen-
eration of GABA neurons, with regeneration declining 10-fold in
this time period (Figure 2D). By contrast, the accumulation of
morphological defects in uninjured GABA neurons is much
slower: no defects are observed at 8 days (Toth et al., 2012),
and even at 10 days of adult life, not all animals have accumu-
lated GABA neuron defects (Tank et al., 2011). Together, these
data suggest that DAF-16 has multiple independent protective
functions in aging neurons.
Conserved Regeneration Mechanisms in C. elegans
PTEN and TOR also regulate GABA axon regeneration. In mutant
animals that lack daf-18/PTEN, an increase in TOR activity re-
sults in increased regeneration (Figure 6). Like daf-16/FOXO,
the effect of PTEN and TOR on axon regeneration is intrinsic to
the nervous system (Figure 5G). However, the effect of PTEN
and TOR on axon regeneration differs from that of daf-16/
FOXO in that daf-18/PTEN regulates axon regeneration in both
young and aged adult animals (Figures 5A and 5B). In mice,
PTEN disruption promotes axon regeneration of retinal ganglion
cells (Park et al., 2008), peripheral sensory (sciatic) neurons
(Christie et al., 2010), and corticospinal neurons (Liu et al.,
2010). Further, at least in the CNS, the full effect of PTEN deletion
on axon regeneration requires mTOR activation (Liu et al., 2010;
Park et al., 2008). In Drosophila, disrupting PTEN promotes axon
regeneration of the class IV dendritic arborization (da) neurons
(Song et al., 2012b). Thus, PTEN and TOR signaling have
emerged as major conserved regulators of axon regeneration,
and increasing TOR activity may be useful for improving regen-
eration, particularly in combination with other proregenerative
manipulations (Sun et al., 2011).
Our data establish C. elegans as a new model for studying the
function of PTEN, TOR, and FOXO in axon regeneration. The
conservation of PTEN and TOR functions in axon regenera-
tion—along with conservation of the DLK-1 pathway (Hammar-
lund et al., 2009; Itoh et al., 2009; Shin et al., 2012; Watkins
et al., 2013; Xiong et al., 2010; Yan et al., 2009), calcium signaling
(Ghosh-Roy et al., 2010; Pichichero et al., 1973; Spencer andNeuron 81, 561–573, February 5, 2014 ª2014 Elsevier Inc. 569
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(Ghosh-Roy et al., 2012; Hellal et al., 2011; Sengottuvel et al.,
2011)—suggests that axon regeneration itself, and the intrinsic
molecular mechanisms that regulate it, are of ancient origin
and are functionally conserved across highly divergent species.
Both DAF-16/FOXO and TOR have multiple downstream
effectors and are global regulators of cellular function. TOR
signaling regulates multiple functions via one of two complexes,
TORC1 or TORC2. These functions include nutrient sensing, cell
growth, actin organization, cytoskeletal dynamics, autophagy,
and stress response (Guertin and Sabatini, 2007). DAF-16/
FOXO is a transcription factor that, when activated—as in daf-
2() mutants—regulates the expression of a large number of
target genes (Kenyon et al., 1993; Murphy et al., 2003; Schuster
et al., 2010; Oh et al., 2006). DAF-16’s many functions
include metabolism, lifespan, synapse maintenance, and axon
morphology (Murphy, 2006; Pan et al., 2011; Tank et al., 2011;
Toth et al., 2012). Our data suggest that one important output
of insulin-FOXO signaling is upregulation of the conserved
dlk-1 regeneration pathway. Further studies will be necessary
to identify other functions of insulin-FOXO signaling in aging neu-
rons and to determine the downstream effectors of PTEN-TOR.
Lifespan and Neuronal Healthspan Are Independent
Phenotypes
In addition to identifying molecular mechanisms that regulate
GABA neuron regeneration in aging animals, our results demon-
strate that the regulation of neuronal repair in aging animals is an
essential component of healthspan, as opposed to lifespan. In
other words, aging and loss of plasticity in neurons is an auton-
omous process that does not depend on overall lifespan. First,
DAF-2/INSR/IGF1R inhibits axon regeneration in older animals
by modulating neuronal DAF-16/FOXO function, and this func-
tion is independent of lifespan. Second, despite functioning
antagonistically to regulate lifespan (Dorman et al., 1995), both
loss of daf-18/PTEN and loss of daf-2 result in increased regen-
eration. Moreover, lifespan and healthspan are distinct at the
cellular level, as DAF-16/FOXO functions in intestinal cells to
regulate lifespan (Libina et al., 2003) and in neurons to regulate
regeneration. Therefore, our results demonstrate that age-
related decline in axon regeneration can be decoupled from
lifespan, and these two effects of time are functionally distinct.
The very early decline of regenerative potential suggests that
the mechanisms described here may modulate a critical inflec-
tion point on the downward curve of neuronal function.
EXPERIMENTAL PROCEDURES
Axotomy Experiments
Axotomy experiments were carried out as previously described (Byrne et al.,
2011). Postaxotomy images were acquired with an Olympus DSU mounted
on an Olympus BX61 microscope, Andor Neo sCMOS camera, and Lumen
light source. Error bars represent 95% confidence intervals. Significance is
indicated with an asterisk (p < 0.01; Fisher’s exact test). Lengths of regenerat-
ing axons were measured with MetaMorph software.
Lifespan Analysis
Lifespans were carried out as previously described (Apfeld and Kenyon, 1999;
Hansen et al., 2008; Hansen et al., 2007; Hsin and Kenyon, 1999) on FUDR570 Neuron 81, 561–573, February 5, 2014 ª2014 Elsevier Inc.plates (Kaeberlein et al., 2005). Animals were plated as L4s (t = 0) and grown
at 25C. Animals that crawled off of the plate or ruptured were censored.
Survival curves were generated with GraphPad Prism. Significance was deter-
mined with the log rank (Mantel-Cox) test. n values were greater than 55 for
each condition tested.
Quantitative RT-PCR
To perform quantitative RT-PCR, total RNA was extracted from 100-worm
samples of N2 or CB1370 with TRIzol and QIAGEN RNeasy. cDNA was
made from 100 ng of total RNA with AffinityScript Multiple Temperature
cDNA synthesis kit. qPCR was performed with Power SYBR green from
Applied Biosystems and cycled on an Applied Biosystems 7,500 Fast system.
All reactions were repeated multiple times: three technical replicates for each
of two biological replicates were performed. No-reverse transcriptase and no-
template controls were included in each experiment. Two to three endogenous
controls were included in each experiment, and all data was normalized to
ama-1. Error bars represent 95% confidence intervals.
Rapamycin
Wormswere grown on rapamycin at a previously reported effective concentra-
tion for C. elegans culture (Robida-Stubbs et al., 2012).
Chromatin Immunoprecipitation-Deep Sequencing
ChIP-seq was performed essentially as described in Zhong et al. (2010) for two
technical replicates of each strain analyzed, with the following modifications.
Synchronized populations of worms were grown on peptone-enriched plates
seeded with OP50 and were collected at the L4 stage. Worms were fixed in
2% formaldehyde in M9 buffer for 30 min at room temperature. Worm pellets
were sonicated to prepare protein lysate containing chromatin sheared
between 100–1000 bp using a Sonic Dismembrator (Fisher). Immunoprecipita-
tion was completed using 2 mg of protein lysate and 7.5 mg a-GFP (Zhong
et al., 2010) at 4C overnight. One tenth of a fraction of lysate was used to
prepare an input DNA sample.
Library preparation of XE1464 DNA samples for ChIP-seq was completed
essentially as described in Zhong et al. (2010). XE1464 input and ChIP DNA
samples were size selected to enrich for DNA ranging from 180–400 bp.
Libraries prepared from all XE1464 DNA samples were multiplexed as
described in Lefranc¸ois et al. (2009) and were sequenced using the Illumina
GA2 sequencing platform. Library preparation of XE1593 input and ChIP
DNA samples for ChIP-seq was completed using the Ovation Multiplex Library
System (NuGEN), in which additional size selection was not performed.
Libraries prepared from XE1593 DNA samples were sequenced using the
Illumina HiSeq 2000 sequencing platform.
Following sequencing, all samples were uniformly processed using param-
eters established by the modENCODE consortium for the mapping of tran-
scription factor binding sites (C.L. Araya, personal communication; Trinh
et al., 2013). Significantly enriched peaks were called using SPP and IDR anal-
ysis tools (Trinh et al., 2013). Gene annotations for theC. elegans genomewere
compiled from several sources and mapped to genome build WS220. Coding
gene models were collected fromWormbase WS235 and the C. elegansmod-
ENCODE project, which includes the analysis of many RNA-seq data sets to
develop aggregated and improved gene models. Similarly, noncoding RNA
gene models were collected from the C. elegans modENCODE project, Lu
et al. (2011), and Wormbase WS235 (for tRNAs, snoRNAs, snRNAs, miRNAs,
21U-RNAs, etc). Candidate target gene models were assigned based on
closest proximity to the highest point of the binding site, irrespective of
whether the binding site is upstream or downstream of the 50 or 30 end of
the gene (21U-RNAs were excluded from this assignment). In addition, nearby
gene models (both coding and noncoding) are listed but not assigned as the
candidate target gene.
Strains
Strains (detailed in Supplemental Experimental Procedures) were maintained
as previously described at 20C (Brenner, 1974). The progeny of healthy, non-
starved animals were transferred to FUDR plates (Sutphin and Kaeberlein,
2009) at the L4 stage and grown at 25C for the indicated amount of time.
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